Robbins Arroyo LLP Is Investigating the Directors and Officers of Orexigen Therapeutics, Inc.

PR Newswire

SAN DIEGO and LA JOLLA, Calif., Aug. 12, 2013 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Orexigen Therapeutics, Inc. (OREX) ("Orexigen") breached their fiduciary duties to shareholders.  Orexigen focuses on the development of pharmaceutical product candidates for the treatment of obesity.


Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003,, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to  

Press release link:

Attorney Advertising. Past results do not guarantee a similar outcome.  

Darnell R. Donahue
Robbins Arroyo LLP
(619) 525-3990 or Toll Free (800) 350-6003


View Comments (0)

Recommended for You